Prevalence of heart failure among hospitalized patient with T2D: results of a prospective observational multicenter study (CREDO)

BACKROUND: Heart failure (HF) is in the first place in the structure of cardiovascular death in patients with type 2 diabetes mellitus (T2D). One of the factors determining the prognosis of patients with this pathology is hospitalization. The difficulties of managing patients are related to the heterogeneity of the population. In some cases, HF in patients with T2D remains undiagnosed, and data on the true frequency of HF in patients with T2D and their clinical and laboratory characteristics in real clinical practice remain limited.

AIM: To assess the prevalence of HF, clinical and demographic characteristics and therapy profile in patients with T2D admitted to multidisciplinary hospitals.

MATERIALS AND METHODS: A prospective observational multicenter study was conducted at the city clinical hospitals of the Moscow. For the period from August 2022 to April 2023, data from patients with T2D were analyzed. Data collection was carried out at one visit. The study design did not involve any intervention in routine clinical practice, including the choice of diagnostic method or treatment.

RESULTS: The study included 445 patients in accordance with the main inclusion criteria - T2D, age over 50 years, duration of T2D more than 3 years. The incidence of HF in patients with type 2 diabetes at discharge was 76.6%. The diagnosis of HF was confirmed in 48.7% (n=217), newly diagnosed HF occurred in 27.9% (n=124) of cases, in 12.6% of patients (n=56) the diagnosis of HF was withdrawn, in 10.8% (n=48) of cases the diagnosis of HF was not established. The frequency of prescribing drugs at discharge was iSGLT-2 — 77.3% (n=344), statins — 86.7% (n= 386), MRAs — 23.1% (n=103), diure­tics — 46.1% (n=205).

CONCLUSION: 76.6% of patients with T2D admitted to multidisciplinary Moscow hospitals were diagnosed with HF at discharge. The results obtained confirm the possibility of detecting HF and initiating cardioprotective therapy at the hospital stage, using inpatient clinical diagnostic examination, and patients with type 2 diabetes lasting more than 3 years and aged over 50 years can be classified as a high risk group for developing HF.

1. 2020 Clinical practice guidelines for Chronic heart failure. Russian Journal of Cardiology. 2020;25(11):4083. (In Russ.) https://doi.org/10.15829/1560-4071-2020-4083

2. Komajda M, Hanon O, Hochadel M, et al. Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II. Eur Heart J. 2009 Feb;30(4):478-86. https://doi.org/10.1093/eurheartj/ehn539

3. Tuppin P, Cuerq A, de Peretti C, et al. First hospitalization for heart failure in France in 2009: patient characteristics and 30-day follow-up. Arch Cardiovasc Dis. 2013 Nov;106(11):570-85. https://doi.org/10.1016/j.acvd.2013.08.002

4. Dedov II, Shestakova MV, Vikulova OK, et al. Diabetes mellitus in the Russian Federation: dynamics of epidemiological indicators according to the Federal Register of Diabetes Mellitus for the period 2010–2022 // Diabetes mellitus. 2023;26(2):104-123. https://doi.org/10.14341/DM13035

5. Standards of Specialized diabetes care/ Edited by Dedov I.I., Shestakova M.V., Mayorov A.Yu. — 11th Edition — M.; Diabetes Mellitus. 2023; 26(2S):1-231 (in Russ.). https://doi.org/10.14341/DM13042

6. Bondarenko IZ, Bubnova MG. Type 2 diabetes mellitus and chronic heart failure: new treatment strategies. Cardiosomatics. 2021;12(4):234–238. https://doi.org/10.17816/22217185.2021.4.201062

7. Petunina N.A. Heart failure and diabetes mellitus: insight into comorbidity // Diabetes Mellitus. — 2019;22(1):79-87. https://doi.org/10.14341/DM9784

8. Yeshniyazov NB, Medovchshikov VV, Safarova AF, et al. Prevalence, clinical characteristics, and echocardiographic phenotypes of heart failure in patients with type 2 diabetes mellitus. Clin Pharmacol Ther 2020; 29(4):44-8 (In Russ.). https://doi.org/10.32756/0869-5490-2020-4-44-48

9. Boonman-de Winter LJ, Rutten FH, Cramer MJ, et al. High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes. Diabetologia. 2012 Aug;55(8):2154-62. https://doi.org/10.1007/s00125-012-2579-0

10. Seferović PM, Petrie MC, Filippatos GS, et al. Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018 May;20(5):853-872. https://doi.org/10.1002/ejhf.1170

11. Reddy YNV, Carter RE, Obokata M, et al. A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction // Circulation. 2018;138:861-70. https://doi.org/10.1161/CIRCULATIONAHA.118.034646

12. McMurray JJ, Gerstein HC, Holman RR, et al. Heart failure: a cardio-vascular outcome in diabetes that can no longer be ignored Lancet Diabetes Endocrinol. 2014;2:843-851. https://doi.org/10.1016/S2213-8587(14)70031-2

13. Maack C, Lehrke M, Backs J, et al. Heart failure and diabetes: meta-bolic alterations and therapeutic interventions: a state-of-the-artreview from the Translational Research Committee of the Heart Failure Association-European Society of Cardiology. Eur Heart J. 2018;39:4243-4254. https://doi.org/10.1093/eurheartj/ehy596

14. Birkeland KI, Bodegard J, Norhammar A, et al. How representativeof a general type 2 diabetes population are patients included in car-diovascular outcome trials with SGLT2 inhibitors? A large Europeanobservational study. Diabetes Obes Metab.2019;21:968-974. https://doi.org/10.1111/dom.13612

15. Braunwald E. Diabetes, heart failure, and renal dysfunction: thevicious circles. Prog Cardiovasc Dis. 2019;62:298-302. https://doi.org/10.1016/j.pcad.2019.07.003

16. Gottdiener JS, Arnold AM, Aurigemma GP, et al. Predictors of con-gestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol. 2000;35:1628-1637. https://doi.org/10.1016/s0735-1097(00)00582-9

17. van Melle JP, Bot M, de Jonge P, et al. Diabetes, glycemic control, and new-onset heart fail-ure in patients with stable coronary artery disease: data from theheart and soul study. Diabetes Care. 2010;33:2084-2089. https://doi.org/10.2337/dc10-0286

18. Bertoni AG, Hundley WG, Massing MW, et al. Heart failure prevalence, incidence, and mortality in theelderly with diabetes. Diabetes Care.2004;27:699-703. https://doi.org/10.2337/diacare.27.3.699

19. LJM Boonman-de Winter, FH Rutten, MJ M Cramer, et al. High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes. Diabetologia (2012) 55:2154–2162. https://doi.org/10.1007/s00125-012-2579-0